Oxford Sciences News Today

Top five consumer industry venture financing deals in Europe in September 2022, according to GlobalData

More than 80 employers in Oxford are now signed up the Oxford Living Wage scheme.

Property consultancy Bidwells has acquired a planning consultancy specialising in higher education and development within Oxford.

Oxford, UK-based OMass Therapeutics closed on a $100 million Series B financing round. The round was led by new investors GV (formerly Google Ventures), Northpond Ventures and Sanofi Ventures. Three existing investors also participated: Syncona, Oxford Science Enterprise and Oxford University.

Nucleome Therapeutics appoints Dr Phil Boyd as Chief Financial Officer Phil brings more than 20 years of top-flight financial experience in the life sciences industry Oxford, UK

Nucleome Therapeutics appoints Nigel Clark as Chief Business Officer Nigel brings 20+ years of commercial and senior managerial experience in the biotech and pharma industry Oxford, UK

Investegate announcements from Lowland Inv. Co., Annual Financial Report

Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics Study conducted by Nucleome's academic founders at the University

Investegate announcements from Nucleome Therapeutics, Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics

Press release content from PR Newswire. The AP news staff was not involved in its creation.